A U.S. jury in the first trial against Wyeth's hormone replacement drug Prempro found that the company was not negligent and did adequately warn patients and doctors of the risk of cancer.
Analysts say also say Plaintiffs' lawyers will have a tougher time proving a disease link to Premarin and Prempro than they did with the diet drugs and a tougher time proving that Wyeth failed to inform patients and doctors' about potential risks for the hormone drugs.
For more, go here.
